Clinical trial
A Phase II Study of Gefitinib in Benefited Patients With Asymptomatic Brain Metastasis Advanced Non-Small Cell Lung Cancer by Chemotherapy
NCT00614809 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Gefitinib in Benefited Patients With Asymptomatic Brain Metastasis Advanced Non-Small Cell Lung Cancer by Chemotherapy
- Lead sponsor
- Guangdong Provincial People's Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 31, 2007
- Completion date
- December 31, 2010
- Enrollment
- 45 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
brain metastasis, non-small cell lung cancer